Updated Jul 16, 2026
Mercer Patrick has filed 3 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $10K. Historical track record: 1/5 stars across 3 tracked purchases.
Patrick Mercer is the President and CEO of IRIDEX Corp, a company specializing in laser-based medical systems for ophthalmology. He has been involved in the company's operations and strategic direction, contributing to its focus on innovative medical technologies.
| Role | Insider |
|---|---|
| Notability | 30/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 0% |
| 90-day win rate | 10000% |
| Avg 5-day return | -711.76% |
| Avg 30-day return | -2428.69% |
| Avg 90-day return | +1883.51% |
| Best 30-day return | -1870.69% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-14 | IRIX | IRIDEX CORP | A — Grant or award | 100.0K | $0.00 | |
| 2026-06-16 | IRIX | IRIDEX CORP | F — Tax withholding / forfeiture | 4.0K | $1.12 | $4K |
| 2026-05-26 | IRIX | IRIDEX CORP | F — Tax withholding / forfeiture | 19.2K | $1.01 | $19K |
| 2025-10-01 | IRIX | IRIDEX CORP | F — Tax withholding / forfeiture | 23.9K | $1.13 | $27K |
| 2025-06-30 | IRIX | IRIDEX CORP | F — Tax withholding / forfeiture | 4.2K | $0.88 | $4K |
| 2025-06-17 | IRIX | IRIDEX CORP | A — Grant or award | 33.4K | $2.00 | $67K |
| 2025-06-13 | IRIX | IRIDEX CORP | A — Grant or award | 33.4K | $0.94 | $31K |
| 2025-05-22 | IRIX | IRIDEX CORP | F — Tax withholding / forfeiture | 14.3K | $0.99 | $14K |
| 2025-04-24 | IRIX | IRIDEX CORP | P — Open-market purchase | 4.5K | $1.29 | $6K |
| 2025-04-24 | IRIX | IRIDEX CORP | P — Open-market purchase | 3.0K | $1.30 | $4K |
| 2025-04-24 | IRIX | IRIDEX CORP | P — Open-market purchase | 46 | $1.15 | $53 |
| 2024-11-08 | IRIX | IRIDEX CORP | A — Grant or award | 200.0K | $0.00 |
Patrick Mercer is the President and CEO of IRIDEX Corp, a company specializing in laser-based medical systems for ophthalmology. He has been involved in the company's operations and strategic direction, contributing to its focus on innovative medical technologies.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 3 open-market purchases ($10K) and 0 open-market sales () across all tracked filings.
Across 3 tracked purchases, Mercer Patrick averaged -2428.7% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mercer Patrick profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.